Mixed trend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend up since Oct 8 · above the Ichimoku cloud · RSI 70 · MACD above its signal
None of the 29 investors followed here reported a position in SIG.AX in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SIG.AX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Verrocchi (Mario)Divisional Officer | Purchase at price 1.81 per share. | 2.00M | $3.62M |
| Sep 13, 2026 | Mitchell (Neville John)Director (Non-Executive) | Purchase at price 1.89 per share. | 20K | $37.90K |
| Nov 9, 2025 | Carey (Annette)Independent Non-Executive Director | Purchase at price 2.04 per share. | 10K | $20.41K |
| Aug 27, 2025 | Gance (Jack)Director (Non-Executive) | Sale at price 2.02 per share. | 155.10M | $313.98M |
| Jun 29, 2025 | Davis (Mark)Chief Financial Officer | — | 2.70M | — |
| Jun 29, 2025 | Spargo (Kathryn Dianne)Former | — | 719.7K | — |
| May 28, 2025 | Pilla (Danielle Di)Director (Executive) | Sale at price 2.05 per share. | 7.34M | $15.02M |
| May 27, 2025 | Pilla (Danielle Di)Director (Executive) | Sale at price 2.06 per share. | 7.50M | $15.42M |
| May 26, 2025 | Pilla (Danielle Di)Director (Executive) | Sale at price 2.03 per share. | 14.76M | $30.03M |
| May 25, 2025 | Pilla (Danielle Di)Director (Executive) | Sale at price 2.04 per share. | 235.3K | $480.60K |
| May 8, 2025 | Gance (Damien)Director (Non-Executive) | Sale at price 1.94 per share. | 126.50M | $244.92M |
| Apr 13, 2025 | Gance (Damien)Director (Non-Executive) | Sale at price 1.88 per share. | 100.00M | $187.85M |
| Feb 13, 2025 | Gance (Damien)Director (Non-Executive) | Sale at price 1.90 per share. | 40.00M | $76.20M |
| Feb 13, 2025 | Ramsunder (Vikesh)Chief Executive Officer | — | 3.13M | — |
| Feb 12, 2025 | Ramsunder (Vikesh)Chief Executive Officer | — | 11.66M | — |
| Feb 11, 2025 | Pilla (Danielle Di)Director (Executive) | — | 105.47M | — |
| Feb 11, 2025 | Gance (Damien)Director (Executive) | — | 400.24M | — |
| Feb 11, 2025 | Gance (Jack)Director (Non-Executive) | — | 1.58B | — |
| Feb 11, 2025 | Verrocchi (Mario)Divisional Officer | — | 2.56B | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.1 | -8.1 | -6.7 | 5.3 | 5.4 | -6.5 | 6.9 | -8.5 | -3.7 | 8.5 | −4.4% | ||
| 2025 | 9.5 | 2.4 | -2.0 | 4.9 | 3.3 | -4.2 | -3.3 | 8.0 | -4.8 | 4.7 | -7.4 | 2.1 | +12.2% |
| 2024 | 3.0 | 10.6 | 13.1 | -2.3 | -0.8 | 1.6 | 2.0 | -3.1 | 14.3 | 36.1 | 47.4 | -9.3 | +160.7% |
| 2023 | 4.1 | 7.1 | 2.9 | 0.0 | -7.1 | 29.2 | -6.5 | 1.9 | -13.8 | -6.5 | 8.5 | 48.0 | +69.8% |
| 2022 | -6.2 | 7.8 | 6.2 | -2.9 | 0.0 | 16.0 | 6.9 | 10.5 | -2.2 | -5.2 | 2.4 | -6.2 | +27.1% |
| 2021 | 7.3 | 0.8 | 2.3 | -11.8 | 2.5 | -3.3 | 5.9 | 2.4 | -3.9 | -8.1 | -8.8 | -7.7 | −22.0% |
| 2020 | 3.4 | -7.5 | 15.3 | -5.5 | -4.1 | 7.8 | 6.4 | 2.3 | -13.2 | -10.2 | 5.7 | 9.8 | +6.0% |
| 2019 | -5.3 | 13.9 | -14.6 | 0.0 | 0.0 | 5.7 | 7.2 | 7.6 | -6.2 | -3.3 | 19.0 | -15.9 | +1.8% |
| 2018 | -9.6 | -0.6 | -12.4 | -0.6 | 1.3 | 3.2 | -39.5 | 16.3 | 10.5 | -17.5 | -5.8 | 16.3 | −42.4% |
| 2017 | -6.6 | -2.5 | 9.8 | -3.1 | -34.8 | 9.8 | 7.3 | -10.9 | -3.5 | -8.5 | 4.6 | 25.3 | −23.3% |
| 2016 | -5.2 | 1.2 | 27.7 | 3.8 | 11.8 | -8.1 | 14.6 | -5.8 | 16.0 | -6.0 | -7.5 | 4.9 | +49.1% |
| 2015 | 8.1 | 14.4 | -2.7 | -2.2 | 0.0 | -11.5 | 13.0 | -7.5 | -7.5 | 12.8 | 3.6 | -0.6 | +16.9% |
| 2014 | -8.5 | 6.7 | 4.7 | 9.0 | -2.1 | 2.8 | 7.5 | 5.1 | -4.2 | -1.9 | -5.2 | 0.7 | +13.8% |
| 2013 | -9.5 | -0.8 | 12.1 | -1.4 | 9.6 | -1.9 | -15.9 | -3.0 | -9.4 | -1.7 | 3.5 | 10.2 | −11.6% |
| 2012 | 9.1 | 1.7 | 3.3 | 5.6 | -8.3 | 0.0 | -0.8 | 13.2 | -6.6 | 5.5 | 0.0 | 8.9 | +33.6% |
| 2011 | 11.3 | 0.0 | 10.1 | -24.5 | 2.7 | 39.5 | -14.2 | 12.1 | 27.5 | 7.7 | -7.1 | -15.4 | +37.5% |
| 2010 | -5.6 | -3.7 | -48.3 | -3.2 | 18.9 | -21.5 | 3.6 | 8.0 | 2.1 | -6.2 | 3.3 | -14.0 | −59.6% |
| 2009 | 11.1 | -11.7 | 0.0 | 5.7 | -11.2 | 22.6 | 6.1 | -6.9 | -7.9 | -11.7 | 2.1 | 3.1 | −4.5% |
| 2008 | -6.0 | -7.7 | -9.7 | -5.2 | 4.2 | -20.2 | 1.0 | 30.7 | -8.1 | 5.4 | 1.6 | -15.6 | −32.3% |
| 2007 | -11.4 | -6.8 | 1.6 | -1.2 | -8.5 | -6.6 | -12.7 | -15.7 | -6.1 | 3.8 | 7.6 | -2.4 | −46.7% |
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.
Buy / hold / sell counts
No recent headlines.